Quotient (QTNT) Commences EU Blood Grouping Field Trial
Tweet Send to a Friend
Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validation (V&V) phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE